Sexually transmitted infections in the Netherlands in 2024
R. El-Jobouri, L. Kayaert, M. Visser, D. Sarink, E.L.M. Op de Coul, Z.W. Alexiou, I. van Bergen, A. de Vries, L.E Chanamé Pinedo, K. Bulsink, C. van Bokhoven-Rombouts, J.W. Vanhommerig, A.I. van Sighem, B.H.B. van BenthemRapport
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
M. Maurel, F. Pozo, G. Pérez-Gimeno, S. Buda, M. Sève, B. Oroszi, M. Hooiveld, V. Gomez, L. Domegan, I. Martinez-Baz, M. Ilić, A.S. Carnahan, M.E. Mihai, A. Martínez, L. Goerlitz, V. Enouf, J.K. Horváth, F. Dijkstra, A.P. Rodrigues, C. Bennett, C. Trobajo-Sanmartín, I. Mlinarić, N. Latorre-Margalef, A.E. Ivanciuc, A. Lopez, R. Dürrwald, A. Falchi, G. Túri, A. Meijer, A. Melo, J. O'Donnell, J. Castilla, V.V. Vučina, T.S. Hagey, M. Lazar, M. Kaczmarek, S. Bacci, E. Kissling, VEBIS study teamTijdschriftartikel
